A Review HPLC Method Development and Validation

International Journal of Trend in Scientific Research and Development (IJTSRD)
Volume 7 Issue 4, July-August 2023 Available Online: www.ijtsrd.com e-ISSN: 2456 – 6470
@ IJTSRD | Unique Paper ID – IJTSRD58595 | Volume – 7 | Issue – 4 | Jul-Aug 2023 Page 34
A Review: HPLC Method Development and Validation
Ajay Sanjay Salvi, Mohini S. Khamkar, Dr. Lahu D. Hingane
Department of Quality Assurance, Aditya Pharmacy College, Beed, Maharashtra, India
ABSTRACT
Due to its very effective separations and often high detection
sensitivity, HPLC is the most widely used separation method in
contemporary pharmaceutical and biomedical analysis. The majority
of medications in multiple component dosage forms can be examined
using the HPLC method due to its many benefits, including speed,
specificity, accuracy, precision, and ease of automation. The
development and validation of HPLC procedures are crucial to novel
discoveries, the creation of pharmaceutical medications, and
numerous other investigations involving both humans and animals.
To compare a defined characteristic of the drug substance or drug
product to predetermined acceptance criteria for that characteristic,
an analytical technique is designed. This review provides details on
the numerous steps that go into developing and validating an HPLC
technique. According to ICH Guidelines, validating an HPLC
technique include testing for system appropriateness as well as
accuracy, precision, specificity, linearity, range and limit of
detection, limit of quantification, robustness, and other performance
characteristics.
KEYWORDS: HPLC, Method development, Validation
How to cite this paper: Ajay Sanjay
Salvi | Mohini S. Khamkar | Dr. Lahu D.
Hingane "A Review: HPLC Method
Development and Validation" Published
in International
Journal of Trend in
Scientific Research
and Development
(ijtsrd), ISSN:
2456-6470,
Volume-7 | Issue-4,
August 2023,
pp.34-39, URL:
www.ijtsrd.com/papers/ijtsrd58595.pdf
Copyright © 2023 by author (s) and
International Journal of Trend in
Scientific Research and Development
Journal. This is an
Open Access article
distributed under the
terms of the Creative Commons
Attribution License (CC BY 4.0)
(http://creativecommons.org/licenses/by/4.0)
INTRODUCTION
High Performance Liquid Chromatography (HPLC)
was derived from the classical column
chromatography and, is one of the most important
tools of analytical chemistry today. In the modern
pharmaceutical industry, high performance liquid
chromatography (HPLC) is the major and integral
analytical tool applied in all stages of drug discovery,
development, and production. The preferred approach
for testing the peak purity of new chemical entities,
keeping track of reaction changes during scale-up or
synthesis processes, assessing new formulations, and
performing quality control and assurance on finished
pharmaceutical products is HPLC. The purpose of the
HPLC approach is to attempt to quantify and separate
the primary drug, any contaminants from reactions,
all readily available synthetic intermediates, and any
degradants. One of the most effective tools in
analytical chemistry nowadays is high performance
liquid chromatography. Every material that can
dissolve in a liquid can have its constituents
separated, identified, and quantified using this
technique. HPLC is one of the most precise analytical
techniques that is frequently used to analyse
pharmacological products both quantitatively and
qualitatively as well as to assess their stability. The
stationary phase, or sample solution, is injected into a
porous column, and the mobile phase, or liquid phase,
is pumped through the column at a higher pressure.
The adsorption of solute on stationary phase based on
its affinity towards stationary phase is the separation
principle that is used. The HPLC method has the
following characteristics.
High definition
Quick analysis,
Stainless steel, glass column, and small diameter
Regulated mobile phase flow rate
Somewhat higher mobile phase pressure
HPLC Method Development:
When there are no official methods for a novel
product, methods are devised. Reduce the cost and
time for current (non-pharmacopoeial) items byusing
alternative methods. for increased robustness and
precision. Comparative laboratory data with merits or
demerits are made available when an alternative
approach is suggested to replace the current
procedure. The fundamental objective of the HPLC
method is to attempt and quantify the separation and
quantification of the main active medication, any
reactive impurities, all readily available synthetic
intermediaries, and any degradants.
IJTSRD58595

International Journal of Trend in Scientific Research and Development @ www.ijtsrd.com eISSN: 2456-6470
Steps involved in Method development are.
Understanding the Physicochemical properties of
drug molecule.
Selection of chromatographic conditions.
Developing the approach of analysis.
Sample preparation
Method optimization
Method validation
Understanding drug molecule physicochemical
characteristics:
A drug's physicochemical characteristics are
important for essential part in the development of
methods. One must study the physical characteristics
of the drug molecule, such as its solubility, polarity,
pKa, and pH, in order to build a method. A
compound's physical characteristic of polarity. An
analyst can use it to choose the mobile phase's solvent
and chemical component.6
6 The polarity of the
molecules can be used to explain their solubility.
Solvents that are nonpolar, like benzene, and polar,
like water, do not combine. Like generally dissolves
like, which means that substances with comparable
polarities can be dissolved in one another. The choice
of diluents depends on how soluble the analyte is. The
pH value is often used to determine whether a
substance is acidic or basic. In HPLC, choosing the
right pH for ionizable analytes frequently produces
symmetrical and sharp peaks.
Choosing the chromatographic parameters:
To get the first "scouting" chromatograms of the
sample, a set of basic settings (detector, column,
mobile phase) are chosen during initial technique
development. On reversed-phase separations on a
C18 column with UV detection, they are typically
based. At this point, a choice should be taken
regarding whether to develop an isocratic or a
gradient methodology.
Column Selection:
A chromatograph's beginning point and centrepiece is
a column, of course. An accurate and trustworthy
analysis can be produced by a good chromatographic
separation from a well-chosen column. A poorly used
column can frequently produce unclear, insufficient,
and poor separations, which can produce results that
are unreliable or difficult to understand.
The column is the brains of an HPLC setup. During
technique development, changing a column will have
the biggest impact on the resolution of analytes. The
stationary phase chemistry, retention capability,
particle size, and column dimensions must all be
taken into account when selecting the optimum
column for an application. Hardware, a matrix, and a
stationary phase are the three major parts of an HPLC
column. Several types of matrices, including as silica,
polymers, alumina, and zirconium, are used to
support the stationary phase. The most typical matrix
for HPLC columnsis silica. Silicamatrices have a low
tendency to compress under pressure, are resilient,
simple to derivatize, and are produced with uniform
spherical sizes.
Most organic solvents and low pH solutions have
little effect on the chemical stability of silica. A silica
solid support's drawback is that it will dissolve above
pH 7. For application at high pH, silica-supported
columns have recently been created.
Separation is influenced by the silica support's
composition, shape, and particle size. Increased or
more theoretical plates are produced by smaller
particles. Whether type of chromatography—normal
phase or reverse phase—a column is best suited for
depends on the characteristics of the stationary phase.
Normal phase chromatography utilizes a polar
stationary phase and a non-polar mobile phase.
Generally, more polar compounds elute later than
non-polar compounds. Commonlyused reverse phase
columns and their uses are listed below. Propyl (C3),
Butyl (C4), and Pentyl (C5) Phases are helpful for
large molecules, hydrophobic peptides, and ion-
pairing chromatography (C4). Comparing C3-C5
phases to C8 or C18 phases, non-polar solutes are
often retained less well by C3-C5 columns. Zorbax
SB-C3, YMC-Pack C4, and Luna C5 are a few
examples. Compared to columns with longer alkyl
chains, these columns are typically less resistant to
hydrolysis. The applications of octyl (C8, MOS)
phases are numerous. While less retention than the
C18 stages, this phase is nonetheless very helpful for
drugs, nucleosides, and steroids. 10 In developing a
method, choosing the stationary phase or column is
the first and most crucial step. Without the
availability of a stable, high performance column, it is
impossible to build a robust and reproducible
procedure. The column production batches from the
same manufacturer as well as columns from other
manufacturers varied in the separation selectivity for
specific components. The key ones include column
dimensions, silica substrate parameters, and bonded
stationary phase qualities. Due to a number of
physical properties, silica-based packing is preferred
in most current HPLC columns.
Chromatographic mode selection:
Polarity and molecular weight-based chromatographic
modes. Reversed-phase chromatography (RPC), the
most typical method for tiny organic compounds, will
be the main topic of all case studies. Ion-pairing
reagents or buffered mobile phases, which retain the
analytes in a non-ionized state, are frequently used in

RPC to separate ionizable chemicals (acids and
bases).
Mobile phase optimization:
Buffer Choice: The system appropriateness
parameters and overall chromatographic performance
of various buffers, including potassium phosphate,
sodium phosphate, and acetate, were assessed.
Impact of pH:
If analytes can be ionised, the correct mobile phase
pH must be selected based on the analyte's pKa so
that the target analyte is in one predominant
ionisation state, either ionised or neutral. One of the
best techniques in the "chromatographer's toolbox"
for changing both retention and selectivity between
important pairs of components simultaneously is
adjusting the pH of the mobile-phase.
Impact of organic modifier:
Choosing an organic modifier type in reverse phase
HPLC is quite straightforward. Acetonitrile and
methanol are often the options (rarely THF). Gradient
elution is typically used with complicated
multicomponent samples since it may not be viable to
elute all components using a single solvent strength
under isocratic conditions between k (retention factor)
1 and 10. 12
Choosing a wavelength and detector:
Following chromatographic separation, the desired
analyte is identified using the appropriate detectors.
Commercial detectors that are utilised in LC include
mass spectrometry (MS) detectors, UV detectors,
fluorescence detectors, electrochemical detectors, and
detectors that measure refractive index (RI).
The sample and the goal of the analysis influence the
detector selection. In the case of multicomponent
analysis, the absorption spectra may have been altered
from the parent chemical to longer or shorter
wavelengths. Due to the various levels of
contaminants in the combination, the UV spectra of
the target analyte and the impurities must be collected
and overlaid, and the spectra must be normalised. It is
necessary to select a wavelength that will allow for a
sufficient response for the majority of the analytes.
Creating the analytical strategy:
The selection of several chromatographic parameters,
such as the mobile phase, column, flow rate, and pH
of the mobile phase, is the initial step in the
development of an analytical technique for RP-
HPLC.
These parameters are all chosen through testing, and
the system suitability parameters are taken into
account afterwards. Retention time should be greater
than 5 minutes, theoretical plates should be greater
than 2000, the tailing factor should be less than 2,
resolution between 2 peaks should be greater than 5,
and the R.S.D. of the area of analyte peaks in
standard chromatograms should not be greater than
2.0%, among other parameters that indicate a system
is suitable.
When two components are estimated simultaneously,
the detection wavelength is often at its isobestic point.
Sample preparation:
The analyst must look at the sample preparation phase
of method development. For instance, if the sample
contains insoluble components, the analyst should
determine whether centrifugation (choosing the best
rpm and time), shaking, and/or filtration of the sample
are necessary. The purpose is to show that the sample
filtration has no impact on the analytical outcome
caused by leachable adsorption and/or extraction.
Syringe filters' efficiency is largely dependent on its
capacity to filter out impurities and insoluble
substances without introducing unwanted artefacts
(i.e.,extractables) into the filtrate. Whether using an
actual in-process sample or a dosage form for a future
HPLC analysis, the sample preparation process
should be adequately specified in the applicable
analytical technique. The manufacturer, type, and
pore size of the filter media must be mentioned in the
analytical technique. The goal of sample preparation
is to transform a raw sample into a processed sample
that yields superior analytical results to the raw
sample. The prepared sample should be an aliquot
that is compatible with the HPLC process and won't
harm the column, and it should be reasonably clear of
interferences.
Method optimization:
The improvement of HPLC conditions has received
the majority of attention throughout HPLC method
development optimization. It is necessary to consider
the compositions of the fixed and mobile phases.
Mobile phase parameter optimization is always
prioritised since it is more practical and
straightforward than stationary phase optimization.
Only the parameters that are likely to have a
significant impact on selectivity in the optimization
must be looked at in order to reduce the amount of
trial chromatograms required. The various elements
of the mobile phase serve as primary control variables
in the optimization of liquid chromatography (LC)
techniques.
Calculating the gradient, flow rate, temperature,
sample amounts, injection volume, and solvent type
of the diluents. Following satisfactoryselectivity, this
is utilised to identify the ideal balance between
resolution and analysis time. The variables include
flow rate, column packing particle size, and column

dimensions. Changes to these parameters won't have
an impact on selectivity or capacity factor.
Method Validation:
An analytical method is validated when it has been
proven through laboratory tests that its performance
characteristics are appropriate for the intended
analytical application. Any new or modified method
needs to be validated to make sure it can produce
repeatable and reliable results when applied by
various operators using the same equipment in the
same or other laboratories. The specific approach and
the applications it is intended for determine exactly
what kind of validation program is necessary. A
crucial component of any sound analytical procedure,
method validation data can be used to assess the
calibre, dependability, and consistency of analytical
findings. The method validation process is
fundamentally dependent on the use of equipment
that is within specification, operating correctly, and
having a sufficient calibration. It is necessary to
validate or revalidate analytical techniques.
Before they are used frequently
Whenever the criteria for which the method has
been approved change
Whenever the technique is modified
The following are typical parameters that the
FDA, USP, and ICH recommend.
1. Specificity
2. Range and Linearity
3. Precision
Technique specificity (Repeatability)
Intermediate accuracy (Reproducibility)
4. Accuracy (Recovery)
5. Stability of the solution
6. Limit of Detection (LOD)
7. Limit of Quantification (LOQ)
8. Robustness
9. System Suitability
Specificity: Selectivity of an analytical method is the
capacity to detect an analyte accurately in the
presence of interfering substances, such as synthetic
precursors, excipients, enantiomers, and known or
likely degradation products that maybe anticipated to
be present in the sample matrix.
Range and linearity: The capacity of an analytical
technique to produce test results that are inversely
proportional to the concentration of analyte in the
sample is known as linearity. It is important to assess
a linear relationship over the entire analytical
procedure. By diluting a standard stock solution of
the drug product's constituent parts according to the
suggested process, it is directly proven on the drug
substance. The confidence limit surrounding the slope
of the regression line is typically used to express
linearity. The ICH recommendation recommends
using a minimum of five concentrations to establish
linearity. The range between the upper and lower
levels that can be determined using an analytical
method with verified precision, accuracy, and
linearity is known as the range of the method.
Precision: The degree of scatter between a set of
measurements obtained from multiple sampling of the
same homogeneous sample under the specified
conditions is expressed as the closeness of agreement
(precision) of an analytical procedure. There are three
types of accuracy: repeatability, intermediate
precision, and reproducibility. The standard deviation
or relative standard deviation of a sequence of data is
typically used to express the precision of an analytical
technique. The degree of reproducibility or
repeatability of the analytical technique under ideal
circumstances might be referred to as precision.
Ruggedness, or intermediate precision, expresses
variability within laboratories, such as on different
days or with different analysts or equipment within
the same laboratory. By testing an adequate number
of aliquots of a homogeneous sample, one can
evaluate the precision of an analytical technique by
calculating statistically accurate estimates of the
standard deviation or relative standard deviation.
Accuracy (Recovery): The accuracy of an analytical
technique expresses how closely the value found and
the value accepted as either a conventional true value
or an approved reference value agree. Applying the
technique to samples that have known dosages of
analyte added yields the result. To make sure there is
no interference, these should be compared to both
standard and blank solutions.
The accuracy is then computed as a percentage of the
analyte recovered by the assay using the test findings.
The recovery by the test of known, added amounts of
analyte is a common way to represent it.
Stability of solutions: During validation, the stability
of standards and samples is established under normal
circumstances, normal storage circumstances, and
occasionally in the instrument to ascertain whether
special storage circumstances, such as refrigeration or
protection from light, are required.
Limit of Detection (LOD): The lowest amount of
analyte in a sample that can be detected but not
necessarily quantitated as an accurate value is known
as the limit of detection (LOD) of a specific method.
The LOD can be predicated on a signal-to-noise (S/N)
ratio (3:1), which is typically reported as the
concentration of analyte in the sample, in analytical
techniques that exhibit baseline noise. The signal-to-

noise ratio is calculated using the formula: s = H/h,
where H is the height of the component-specific peak.
The highest noise deviation from the chromatogram
of a blank solution's baseline, expressed in absolute
terms, is given by the formula h.
Limit of Quantification (LOQ): The smallest
amount of analyte in a sample that can be
quantitatively identified with adequate precision and
accuracy is known as the limit of quantification
(LOQ), also known as the quantitation limit of a
specific analytical process. The LOQ is typically
estimated from a determination of S/N ratio (10:1) for
analytical processes like HPLC that exhibit baseline
noise, and is typically confirmed by injecting
standards that yield this S/N ratio and have an
acceptable percent relative standard deviation as well.
Robustness: Robustness is a measure of an analytical
method's capacity to stay unaffected by minute but
intentional changes in method parameters (such as
pH, mobile phase composition, temperature, and
instrument settings), and it shows how reliable the
method will be under typical conditions. Determining
robustness is a systematic process that involves
changing a parameter and evaluating the impact on
the methodology through system suitability
monitoring and/or sample analysis.
System Suitability: System compatibilityevaluations
are an essential component of liquid chromatographic
techniques. They are used to confirm that the
chromatographic system's detection sensitivity,
resolution, and reproducibility are sufficient for the
intended analysis. The tests are founded on the idea
that the tools, electronics, analytical processes, and
test samples make up a whole system that may be
assessed as such. To assess the suitability of the
employed approach, variables like peak resolution,
theoretical plate count, peak tailing, and capacity
have been assessed.
Conclusion:
Pharmaceutical analysis has paid a lot of attention
lately to the development of analytical methods for
drug identification, purity assessment, and
quantification.
The development and validation of HPLC methods
are generally covered in this article.
The creation of an HPLC method for the separation
of substances was discussed using a general and very
basic approach. Prior to the development of any
HPLC process, understanding the primary
compound's physiochemical characteristics is crucial.
The choice of buffer and mobile phase (organic and
pH) composition has a significant impact on
separation selectivity. The gradient slope,
temperature, flow rate, type, and concentration of
mobile-phase modifiers can all be altered for the final
optimization. According to ICH criteria, the
optimised method is verified using a variety of factors
(such as specificity, precision, accuracy, detection
limit, linearity, etc.).
Abbreviations
HPLC High Performance Liquid Chromatography
ICH International conference on Harmonization
Id Internal Diameter
LC Liquid Chromatography
LOD Limit of Detection
LOQ Limit of Quantitation
m Meter
mm Mili meter
MS Mass Spectrometry
ODS Octyl decyl silane
RI Refractive index
THF Tetrahydrofuran
USP United states Pharmacopeia
µm Micron
Reference:
[1] Gurdeep R. Chatwal and Sham k. Anand,
Instrumental Method of Chemical Analysis,
Fifth Revised & Enlarged Edition 2002; 2.624-
2.638.
[2] Dr. Shashikant D. Barhate, Dr. MD. Rageeb
MD. Usman, Poonam A. Salunke, Shital S.
Patil, Textbook of Modern pharmaceutical
Analytical Techniques, Jan-2019; 258-277.
[3] Sethi PD, HPLC: Quantitative Analysis of
Pharmaceutical Formulation, New Delhi, CBS
Publishers and Distributors, 1996; 113-202.
[4] Santosh Kumar Bhardwaj a,b *, K. Dwivedia
and D. D. Agarwala A Review: HPLC Method
Development and Validation, International
Journal of Analytical and Bioanalytical
Chemistry, Nov 2015
[5] V. Gupta, A.D. K. Jain, N.S. Gill, K. Gupta,
Development and validation of HPLC method -
a review , Int. Res J Pharm. App Sci., 2(4)
(2012) 17-25
[6] Y. Kazakevich, R. Lobrutto, HPLC for
Pharmaceutical Scientists, John Wiley & Sons,
New Jersey, 2007.
[7] S. Ahuja, H. Rasmussen, Development for
Pharmaceuticals, Vol.8 Separation Science and
Technology, Elsevier, New York 2007

[8] M.S. Azim, M. Mitra, P.S. Bhasin, HPLC
method development and validation: A review,
Int. Res. J. Pharm. 4(4) (2013) 39-46.
[9] B.V. Rao, G.N. Sowjanya1, A. Ajitha, V.U.M.
Rao, Review on stability indicating hplc
method development, World Journal of
Pharmacy and Pharmaceutical Sciences, 4(8)
(2015) 405-423.
[10] M.W. Dong, Modern Hplc for practicing
scientists, John Wiley & Sons, New Jersey,
2006.
[11] Kumar V, Bharadwaj R, Gupta G, Kumar S. An
Overview on HPLC Method Development,
Optimization and Validation process for drug
analysis. The Pharmaceutical and Chemical
Journal. 2015; 2(2):30-40.
[12] HPLC – Chemiguide. May 2, 2007.
www.chemguide.co.uk
[13] N.Toomula, A. Kumar, S.D.Kumar, V.S.
Bheemidi, Development and Validation of
Analytical Methods for Pharmaceuticals, J Anal
Bioanal Techniques. 2(5) (2011) 1-4.

A Review HPLC Method Development and Validation

More Related Content

What's hot (20)

Similar to A Review HPLC Method Development and Validation (20)

More from ijtsrd (20)

Recently uploaded (20)

A Review HPLC Method Development and Validation